Shot Tower Capital confirms Hipgnosis valuation amid damning due diligence report
Also concludes HSF held a ‘conflicted position’ when recommending the sale of 29 catalogues to shareholders
The last 10 years have seen ETF products grow from pre-teens to fully fledged adults, even dabbling with drugs along the way. 7IM’s passive expert and senior investment manager Peter Sleep looks back at the biggest trends.
MORE ARTICLES ON
Also concludes HSF held a ‘conflicted position’ when recommending the sale of 29 catalogues to shareholders
Glavin spent over 16 years at State Street Global Advisors
Redress to be paid out today, almost five years on from fund’s initial suspension
451 properties sold since August 2023
Trust will now pursue a managed wind down instead
Reunites with Newton CEO Euan Munro